Ritalin (Methylphenidate Hcl) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 20, 2017 Category: Drugs & Pharmacology Source Type: news
Mylan launches new ADHD treatment in US
US-based pharmaceuticals company Mylan has launched the Methylphenidate Hydrochloride Extended-Release Tablets USP in the country for the treatment of patients affected with attention deficit hyperactivity disorder (ADHD). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - January 3, 2017 Category: Pharmaceuticals Source Type: news
No superiority of treatment with osmotic controlled-release oral delivery system-methylphenidate over short/medium-acting methylphenidate preparations in the rate and timing of injuries in children with attention-deficit/hyperactivity disorder - Golubchik P, Kodesh A, Weizman A.
OBJECTIVES: Methylphenidate (MPH) treatment in patients with attention-deficit/hyperactivity disorder (ADHD) is reported to reduce the risk for injuries. In the present study, the rate and timing of injuries were compared among the various MPH preparations... (Source: SafetyLit)
Source: SafetyLit - December 3, 2016 Category: Global & Universal Tags: Age: Adolescents Source Type: news
ADHD Drug Plus Therapy Improves Cognitive Outcomes In TBI Patients
Study reveals combination of methylphenidate with cognitive-behavioral rehabilitation a promising option for people with persistent cognitive problems following traumatic brain injury (Source: Disabled World)
Source: Disabled World - November 25, 2016 Category: Disability Tags: Traumatic Brain Injury Source Type: news
Adding ADHD drug to therapy improves cognitive outcomes in traumatic brain injury patients
(Indiana University) A combination of the stimulant drug methylphenidate with a process known as cognitive-behavioral rehabilitation is a promising option to help people who suffer from persistent cognitive problems following traumatic brain injury, researchers at Indiana University School of Medicine have reported. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 22, 2016 Category: Global & Universal Source Type: news
Metadate ER (Methylphenidate Hydrochloride Extended Release Tablet) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 7, 2016 Category: Drugs & Pharmacology Source Type: news
Quillichew ER (Methylphenidate Hydrochloride Extended-release Chewable Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 31, 2016 Category: Drugs & Pharmacology Source Type: news
Methylphenidate Ups Arrhythmia Risk in Kids
The relative risk of CV events with methylphenidate is generally low; however risk of MI may be higher in the early days after initiation. (Source: ConsultantLive)
Source: ConsultantLive - September 20, 2016 Category: Internal Medicine Authors: Veronica Hackethal, MD Tags: ADHD Source Type: news
Daytrana (Methylphenidate Transdermal) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 7, 2016 Category: Drugs & Pharmacology Source Type: news
In Klinefelter Syndrome Patients, What are the Common Behavioral Problems?
Discussion
Klinefelter syndrome (KS) is a common genetic abnormaly with a prevalence of 1 in ~650 male births. It was first described in 1942 by Dr. Harry Klinefelter. It is associated with at least one extra X chromosome with the most common karyotype (~80% of patients) being 47 XXY. Other karyotypes are seen along with mosaicism. It is believed that although it is very prevalent, only about 25-33% of people with KS are identified. About 10% are identified before puberty with the rest usually identified because of hypogonadism and tall stature especially in teenage years or due to infertility in adulthood. KS is diagnosed...
Source: PediatricEducation.org - August 29, 2016 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
ADHD Med Linked to Brain Changes in Kids After Stopping ADHD Med Linked to Brain Changes in Kids After Stopping
Children treated with methylphenidate for ADHD show brain changes after discontinuing the drug, suggesting ' neurochemical imprinting ' on the developing brain, with uncertain long-term consequences.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 9, 2016 Category: Consumer Health News Tags: Psychiatry News Source Type: news
Cardiovascular Safety of Methylphenidate Use in ADHDCardiovascular Safety of Methylphenidate Use in ADHD
There is conflicting evidence regarding the cardiac safety of stimulant use, especially in children. Does methylphenidate use in ADHD put children and young people at risk for adverse CV events? British Medical Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 24, 2016 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news
Ritalin Could Trigger Heart Problems In Children
Ritalin and similar forms of ADHD medication may trigger abnormal heart rhythms and increase heart attack risk in some children soon after they start taking the drug, according to a new study.
This connection was especially true for children who were born with heart disease.
According to the study, published in the British medical journal BMJ, kids had an increased risk of heart attack between eight and 56 days after starting methylphenidate, a stimulant most commonly sold as Ritalin, although this heightened risk didn’t reach statistical significance. The researchers could find no evidence of a heightened...
Source: Science - The Huffington Post - June 8, 2016 Category: Science Source Type: news
ADHD Medication May Boost Kids' Arrhythmia RiskADHD Medication May Boost Kids' Arrhythmia Risk
Children and young people prescribed methylphenidate, commonly used in ADHD, have an increased risk for arrhythmia in the weeks after initiation of treatment. Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - June 7, 2016 Category: Psychiatry Tags: Psychiatry News Source Type: news
